Analyst Summary
Genpharmasec Ltd operates in the Trading & Distributors segment, NSE: GENPHARMA | BSE: 531592, current market price is ₹1.26, market cap is 69.8 Cr.. At a glance, ROE is 1.90 %, ROCE is 3.35 %, book value is 1.19, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹0.43, around 65.9% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹34 Cr versus the prior period change of 10.4%, while latest net profit is about ₹1 Cr with a prior-period change of 823.5%. The 52-week range shown on this page is 2.38/0.75, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisGenpharmasec Ltd. is a Public Limited Listed company incorporated on 16/11/1992 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L242…
This summary is generated from the stock page data available for Genpharmasec Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.
Investment Snapshot
Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.
Share Price and Basic Stock Data
Last Updated: April 26, 2026, 1:34 am
| PEG Ratio | 0.00 |
|---|
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Millennium Online Solutions (India) Ltd | 7.00 Cr. | 1.40 | 2.88/1.29 | 0.81 | 0.00 % | 4.61 % | 5.54 % | 1.00 | |
| Minal Industries Ltd | 47.6 Cr. | 2.48 | 5.59/1.78 | 116 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 14.9 Cr. | 16.9 | 18.0/11.5 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 | |
| Modella Woollens Ltd | 6.34 Cr. | 69.6 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 111 Cr. | 35.5 | 54.5/10.5 | 124 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| Industry Average | 11,174.41 Cr | 151.14 | 104.64 | 119.05 | 0.43% | 15.22% | 8.81% | 7.62 |
Quarterly Result
| Metric | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6.22 | 7.86 | 6.38 | 10.20 | 5.20 | 6.03 | 8.48 | 14.01 | 12.04 | 32.64 | 39.83 |
| Expenses | 6.01 | 7.89 | 6.37 | 10.21 | 5.00 | 5.90 | 7.76 | 15.01 | 11.10 | 33.10 | 41.07 |
| Operating Profit | 0.21 | -0.03 | 0.01 | -0.01 | 0.20 | 0.13 | 0.72 | -1.00 | 0.94 | -0.46 | -1.24 |
| OPM % | 3.38% | -0.38% | 0.16% | -0.10% | 3.85% | 2.16% | 8.49% | -7.14% | 7.81% | -1.41% | -3.11% |
| Other Income | 0.06 | 0.15 | 0.14 | 0.31 | 0.57 | 0.75 | 0.81 | 0.94 | 0.69 | 0.46 | 0.98 |
| Interest | 0.06 | 0.07 | 0.00 | 0.16 | 0.10 | 0.07 | 0.16 | 0.11 | 0.12 | 0.23 | 0.41 |
| Depreciation | 0.01 | 0.00 | 0.12 | 0.03 | 0.16 | 0.30 | 0.10 | 0.26 | 0.27 | 0.56 | 0.67 |
| Profit before tax | 0.20 | 0.05 | 0.03 | 0.11 | 0.51 | 0.51 | 1.27 | -0.43 | 1.24 | -0.79 | -1.34 |
| Tax % | -420.00% | 80.00% | -100.00% | 345.45% | 35.29% | -39.22% | 40.16% | -37.21% | 2.42% | 48.10% | -37.31% |
| Net Profit | 1.05 | 0.01 | 0.06 | -0.27 | 0.33 | 0.70 | 0.76 | -0.27 | 1.22 | -1.18 | -0.83 |
| EPS in Rs | 0.02 | 0.00 | 0.00 | -0.00 | 0.01 | 0.01 | 0.01 | -0.00 | 0.02 | -0.02 | -0.01 |
Last Updated: March 3, 2026, 9:36 am
Profit & Loss - Annual Report
Last Updated: February 27, 2026, 5:46 am
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|
| Sales | 25.52 | 30.41 | 33.57 | 98.52 |
| Expenses | 25.26 | 30.37 | 33.49 | 100.28 |
| Operating Profit | 0.26 | 0.04 | 0.08 | -1.76 |
| OPM % | 1.02% | 0.13% | 0.24% | -1.79% |
| Other Income | 0.10 | 0.66 | 3.06 | 3.07 |
| Interest | 0.06 | 0.41 | 0.45 | 0.87 |
| Depreciation | 0.02 | 0.04 | 0.81 | 1.76 |
| Profit before tax | 0.28 | 0.25 | 1.88 | -1.32 |
| Tax % | -300.00% | 168.00% | 34.57% | |
| Net Profit | 1.12 | -0.17 | 1.23 | -1.06 |
| EPS in Rs | 0.02 | -0.00 | 0.02 | -0.01 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
Growth
Last Updated: September 5, 2025, 3:36 pm
Balance Sheet
Last Updated: December 4, 2025, 2:57 am
| Month | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|
| Equity Capital | 27.69 | 55.37 | 55.37 | 55.37 |
| Reserves | -12.36 | 9.02 | 9.79 | 10.31 |
| Borrowings | 3.08 | 3.89 | 5.28 | 11.01 |
| Other Liabilities | 1.46 | 2.84 | 9.45 | 47.31 |
| Total Liabilities | 19.87 | 71.12 | 79.89 | 124.00 |
| Fixed Assets | 0.10 | 0.84 | 7.58 | 42.20 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.95 | 19.32 | 18.84 | 2.05 |
| Other Assets | 18.82 | 50.96 | 53.47 | 79.75 |
| Total Assets | 19.87 | 71.12 | 79.89 | 124.00 |
Cash Flow
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
Free Cash Flow
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Free Cash Flow | -2.82 | -3.85 | -5.20 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Debtor Days | 81.67 | 109.22 | 147.21 |
| Inventory Days | 151.06 | 133.17 | 101.29 |
| Days Payable | 21.38 | 35.85 | 102.03 |
| Cash Conversion Cycle | 211.34 | 206.54 | 146.47 |
| Working Capital Days | 199.09 | 213.17 | 141.26 |
| ROCE % | 1.52% | 3.32% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 |
|---|---|---|
| FaceValue | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.02 | -0.01 |
| Diluted EPS (Rs.) | 0.02 | -0.01 |
| Cash EPS (Rs.) | 0.03 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.18 | 1.17 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.18 | 1.17 |
| Revenue From Operations / Share (Rs.) | 0.60 | 0.54 |
| PBDIT / Share (Rs.) | 0.05 | 0.01 |
| PBIT / Share (Rs.) | 0.04 | 0.01 |
| PBT / Share (Rs.) | 0.03 | 0.00 |
| Net Profit / Share (Rs.) | 0.02 | 0.00 |
| NP After MI And SOA / Share (Rs.) | 0.02 | 0.00 |
| PBDIT Margin (%) | 9.27 | 2.30 |
| PBIT Margin (%) | 6.86 | 2.16 |
| PBT Margin (%) | 5.57 | 0.82 |
| Net Profit Margin (%) | 3.65 | -0.55 |
| NP After MI And SOA Margin (%) | 3.58 | -0.41 |
| Return on Networth / Equity (%) | 1.85 | -0.19 |
| Return on Capital Employeed (%) | 3.30 | 0.96 |
| Return On Assets (%) | 1.51 | -0.17 |
| Long Term Debt / Equity (X) | 0.04 | 0.04 |
| Total Debt / Equity (X) | 0.04 | 0.04 |
| Asset Turnover Ratio (%) | 0.44 | 0.00 |
| Current Ratio (X) | 2.78 | 15.16 |
| Quick Ratio (X) | 1.94 | 11.89 |
| Inventory Turnover Ratio (X) | 3.96 | 0.00 |
| Interest Coverage Ratio (X) | 7.19 | 1.72 |
| Interest Coverage Ratio (Post Tax) (X) | 3.83 | 0.58 |
| Enterprise Value (Cr.) | 102.64 | 108.00 |
| EV / Net Operating Revenue (X) | 3.04 | 3.55 |
| EV / EBITDA (X) | 32.83 | 153.89 |
| MarketCap / Net Operating Revenue (X) | 3.10 | 4.06 |
| Price / BV (X) | 1.61 | 1.92 |
| Price / Net Operating Revenue (X) | 3.10 | 4.06 |
| EarningsYield | 0.01 | 0.00 |
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | Office No. 104 & 105 (1st Floor), Gundecha Industrial Premises Co-Operative Society Ltd., Mumbai Maharashtra 400101 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sohan Chaturvedi | WholeTime Director & CFO |
| Mrs. Sneha Sadhwani | Non Exe.Non Ind.Director |
| Mr. Rajesh Sadhwani | Non Exe.Non Ind.Director |
| Mr. Siddhesh Shende | Independent Director |
| Mr. Mayur Bhatt | Independent Director |
| Mr. Sachin Aphandkar | Independent Director |
FAQ
What is the intrinsic value of Genpharmasec Ltd and is it undervalued?
As of 26 April 2026, Genpharmasec Ltd's intrinsic value is ₹0.43, which is 65.87% lower than the current market price of ₹1.26, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (1.90 %), book value (₹1.19), dividend yield (0.00 %), and 5-year EPS CAGR.
What is the current share price and 52-week range of Genpharmasec Ltd?
Genpharmasec Ltd is trading at ₹1.26 as of 26 April 2026, with a FY2026-2027 high of ₹2.38 and low of ₹0.75. The stock is currently in the middle of its 52-week range. Market cap stands at ₹69.8 Cr..
How does Genpharmasec Ltd's P/E ratio compare to its industry?
Genpharmasec Ltd has a P/E ratio of , which is below the industry average of 104.64. This is broadly in line with or below the industry average.
Is Genpharmasec Ltd financially healthy?
Key indicators for Genpharmasec Ltd: ROCE of 3.35 % is on the lower side compared to the industry average of 15.22%; ROE of 1.90 % is below ideal levels (industry average: 8.81%). Dividend yield is 0.00 %.
Is Genpharmasec Ltd profitable and how is the profit trend?
Genpharmasec Ltd reported a net profit of ₹1 Cr in Mar 2025 on revenue of ₹34 Cr. Compared to ₹1 Cr in Mar 2023, the net profit shows an improving trend.
Does Genpharmasec Ltd pay dividends?
Genpharmasec Ltd has a dividend yield of 0.00 % at the current price of ₹1.26. The company is currently not paying meaningful dividends.
